These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32205565)

  • 1. Signatures in drug-induced liver injury.
    Tillmann HL; Rockey DC
    Curr Opin Gastroenterol; 2020 May; 36(3):199-205. PubMed ID: 32205565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT).
    Tillmann HL; Suzuki A; Merz M; Hermann R; Rockey DC
    PLoS One; 2022; 17(9):e0271304. PubMed ID: 36174069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to Diagnose and Exclude Drug-Induced Liver Injury.
    Watkins PB
    Dig Dis; 2015; 33(4):472-6. PubMed ID: 26159261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approach.
    Gonzalez-Jimenez A; Suzuki A; Chen M; Ashby K; Alvarez-Alvarez I; Andrade RJ; Lucena MI
    Arch Toxicol; 2021 May; 95(5):1793-1803. PubMed ID: 33666709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
    Teschke R
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in Australia.
    Nash E; Nicoll A; Batt N; George J; Perananthan V; Prince D; Wallace M; Gow P; Vaz K; Chitturi S; Flores JE; Braund A; Bonnichsen M; Riordan S; Humphris J; Duong T; McKenzie C; Liu K; Strasser SI
    Aliment Pharmacol Ther; 2024 Apr; 59(8):953-961. PubMed ID: 38372012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.
    Björnsson HK; Björnsson ES
    Eur J Intern Med; 2022 Mar; 97():26-31. PubMed ID: 34772600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel phenotype-based drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation in early drug development.
    Hermann RP; Rockey DC; Suzuki A; Merz M; Tillmann HL
    Aliment Pharmacol Ther; 2022 Apr; 55(8):1028-1037. PubMed ID: 35266155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case definition and phenotype standardization in drug-induced liver injury.
    Aithal GP; Watkins PB; Andrade RJ; Larrey D; Molokhia M; Takikawa H; Hunt CM; Wilke RA; Avigan M; Kaplowitz N; Bjornsson E; Daly AK
    Clin Pharmacol Ther; 2011 Jun; 89(6):806-15. PubMed ID: 21544079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
    Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
    J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed diagnosis of cholestatic drug-induced liver injury treated with corticosteroid for adrenal insufficiency secondary to miliary tuberculosis.
    Lee SY; Schneier A; Schiano T; Liu SJ; Machado ON
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3046-9. PubMed ID: 26367727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.
    Aithal GP
    Liver Int; 2015 Jul; 35(7):1801-8. PubMed ID: 25809692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced liver injury].
    Björnsson ES
    Laeknabladid; 2010 Mar; 96(3):175-82. PubMed ID: 20197596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
    Nicoletti P; Aithal GP; Bjornsson ES; Andrade RJ; Sawle A; Arrese M; Barnhart HX; Bondon-Guitton E; Hayashi PH; Bessone F; Carvajal A; Cascorbi I; Cirulli ET; Chalasani N; Conforti A; Coulthard SA; Daly MJ; Day CP; Dillon JF; Fontana RJ; Grove JI; Hallberg P; Hernández N; Ibáñez L; Kullak-Ublick GA; Laitinen T; Larrey D; Lucena MI; Maitland-van der Zee AH; Martin JH; Molokhia M; Pirmohamed M; Powell EE; Qin S; Serrano J; Stephens C; Stolz A; Wadelius M; Watkins PB; Floratos A; Shen Y; Nelson MR; Urban TJ; Daly AK;
    Gastroenterology; 2017 Apr; 152(5):1078-1089. PubMed ID: 28043905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced liver injury: Interactions between drug properties and host factors.
    Chen M; Suzuki A; Borlak J; Andrade RJ; Lucena MI
    J Hepatol; 2015 Aug; 63(2):503-14. PubMed ID: 25912521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: clinical assessment of suspected drug-induced liver injury and its management.
    Vuppalanchi R; Ghabril M
    Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1516-1531. PubMed ID: 36282208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop.
    Fontana RJ; Seeff LB; Andrade RJ; Björnsson E; Day CP; Serrano J; Hoofnagle JH
    Hepatology; 2010 Aug; 52(2):730-42. PubMed ID: 20564754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions and organ damage: The liver.
    Licata A
    Eur J Intern Med; 2016 Mar; 28():9-16. PubMed ID: 26827101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.